NIH Funding · FY2024
Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#7,116
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.7M across 3 grants · National rank #7116.
Top grants by award amount
Fernando Aleman Guillen's NIH grant portfolio, ranked by award amount.
- 5U44NS122114-04U44Preclinical optimization of a gene therapy for erythromelalgia and chronic pain$1.5Maward amount
- 3U44NS122114-04S1U44Preclinical optimization of a gene therapy for erythromelalgia and chronic pain$98.7Kaward amount
- 3U44NS122114-03S1U44Preclinical optimization of a gene therapy for erythromelalgia and chronic pain$74.7Kaward amount
Affiliation
Institutions that have administered grants for Fernando Aleman Guillen.
Affiliated with Navega Therapeutics, Inc. (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardNavega Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7116
Related investigators
Other NIH-funded PIs frequently associated with Fernando Aleman Guillen.
Explore further
Find collaborators for Fernando Aleman Guillen
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Navega Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →